Remarkable ‘clinical studies’ of domestic pharmaceutical companies focusing on future-oriented treatments
Domestic companies have always had desire towards new drugs. However, the problem is it takes so much more time and money to invest in new drugs than generics.
Recently, however, domestic pharmaceutical companies have been liberal with investment on potential fields using the select and concentr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
